International Edition
Latest News
Health

Review: Endosomal pH Master Regulates Coronavirus Entry, Evasion

A new review in Frontiers in Cellular and Infection Microbiology identifies endosomal pH as a master regulator for human pathogenic coronaviruses, controlling viral entry, replication efficiency and immune evasion, while warning that therapeutic targeting of this pathway carries…

Review: Endosomal pH Master Regulates Coronavirus Entry, Evasion

A new review in Frontiers in Cellular and Infection Microbiology identifies endosomal pH as a master regulator for human pathogenic coronaviruses, controlling viral entry, replication efficiency and immune evasion, while warning that therapeutic targeting of this pathway carries significant biological risk.

The paper, received by the journal September 9, 2026, and led by Xusheng Qiu, synthesizes evidence across SARS-CoV-2, SARS-CoV, MERS-CoV and seasonal human coronaviruses. All exploit the acidic endosomal lumen to trigger spike protein conformational changes required for membrane fusion.

The vacuolar ATPase (V-ATPase) pumps protons into the endosome to acidify it; endosomal sodium-hydrogen exchangers (eNHEs) leak protons out to alkalinize it. The review argues that the precise tuning of this balance by eNHEs has been largely understudied compared with the proton-pumping V-ATPase.

“A causal link between endosome luminal pH and coronavirus entry remains to be established,” the authors write, noting that the prevailing model overwhelmingly focuses on V-ATPases.

SARS-CoV-2 variants can bypass the endosome entirely by fusing directly at the plasma membrane when the host protease TMPRSS2 is available, making the entry route dependent on the viral variant, host protease repertoire and cell type.

The authors detail an immune evasion mechanism in which SARS-CoV-2 uses endosome pH-dependent conformational masking to promote antibody shedding, effectively stripping neutralizing antibodies from the virion surface. This positions endosomal acidification as a factor in viral persistence beyond the entry step.

The review evaluates combination regimens pairing pH-modifying agents — such as V-ATPase inhibitors and NHE blockers — with direct-acting antivirals. It identifies critical evidence gaps limiting clinical translation, including the lack of validated causal links between luminal pH and entry efficiency in physiologically relevant models, and the risk of broad cellular toxicity given the universal role of endosomal pH in host physiology.

The study uses veterinary coronaviruses as comparative paradigms rather than co-subjects, focusing analysis on human pathogens. The authors declare no competing interests. The article is distributed under the Creative Commons Attribution License (CC BY).

About the author: Health Desk

Health Desk at Archynewsy.